TOP STORIES

• BUSINESS “Lecture Meeting Fever” as Companies Seek New Ways to Interact with Doctors Under Tougher Restrictions on Settai
  November 5, 2012

• BUSINESS Sales Target for Prasugrel Achievable Despite Add’l Indication Dropped: Daiichi Sankyo Pres. Nakayama
  November 2, 2012

• BUSINESS Takeda’s Japan Sales Ratio Likely to Fall to Mid-30% Range: President Hasegawa
  November 1, 2012

• BUSINESS Mochida, MTPC See Signs of Sales Growth for Lexapro after Lifting of Long-Term Prescription Ban
  October 31, 2012

• BUSINESS Shionogi to Take Part in GSK-Pfizer JV, Realigns Strategy in HIV Field
  October 30, 2012

• BUSINESS Chugai to License SGLT-2 Inhibitor to Kowa, Sanofi
  October 29, 2012

• BUSINESS Janssen’s New MR Training System Aims to Produce “Consulting MRs”
  October 29, 2012

• REGULATORY MHLW to Initially Limit Number of Stores to Offer Epadel OTC
  October 26, 2012

• BUSINESS “Changing Way of Thinking Necessary among Industry, Government, Academia for Promotion of Drug Discovery”: AZ Chairman Kato
  October 25, 2012

• BUSINESS Santen Going on Offensive in Growth Fields in Ophthalmology
  October 24, 2012

• BUSINESS Astellas Poised for Domestic PIIb Trial of Novel IBS Treatment
  October 23, 2012

• BUSINESS MTPC to Dissolve Capital Alliance with Choseido
  October 22, 2012

• REGULATORY Sales Tax Hike Expected to Hasten Separation of Dispensing from Medical Practice by Sapping Yakka-Saeki
  October 19, 2012

• REGULATORY PAFSC Committee Recommends Approval for Switch OTC Version of Epadel 2 Years after Frist Review
  October 18, 2012

• BUSINESS Qol’s Mr Takada Hints at Continued Use of Long-Listed Drugs from Makers Hiring Apo Plus MRs
  October 17, 2012

• BUSINESS MTPC’s Oral MS Treatment Charging towards Blockbuster Territory
  October 16, 2012

• BUSINESS Towa Pharmaceutical Expanding Direct-Sales Network as Its Distributors Face Lack of Successors
  October 15, 2012

• ACADEMIA We Would Like to Provide iPS Cells with Medical History Identification: Prof. Yamanaka of Kyoto University
  October 15, 2012

• BUSINESS Radical AD Treatments Hit “PIII Wall” Again, but Amyloid β Hypothesis Remains Unshaken
  October 15, 2012

• REGULATORY MHLW to Begin Pilot Study on Drug Risk Management Plans for Generics
  October 12, 2012

ページ

• « 先頭
• ‹ Prev
• …
• 225
• 226
• 227
• 228
• 229
• 230
• 231
• 232
• 233
• …
• Next ›
• 最終 »